{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:45:35Z","timestamp":1778841935054,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013132","name":"Mundipharma Pte Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cca.2020.09.005","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T22:23:32Z","timestamp":1599517412000},"page":"760-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Performance of an automated chemiluminescence SARS-CoV-2 IG-G assay"],"prefix":"10.1016","volume":"510","author":[{"given":"C.S.","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3456-3579","authenticated-orcid":false,"given":"H.M.L.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-5694","authenticated-orcid":false,"given":"S.P.","family":"Hoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8332-6003","authenticated-orcid":false,"given":"Y.L.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7486-689X","authenticated-orcid":false,"given":"S.K.","family":"Phua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.C.","family":"Aw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.09.005_b0005","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcp2009249","article-title":"Mild or Moderate Covid-19","author":"Gandhi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.09.005_b0010","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid-19","author":"Berlin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.09.005_b0015","unstructured":"Centers for Disease Control and Prevention, Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19). Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-criteria.html (accessed May 22, 2020)."},{"key":"10.1016\/j.cca.2020.09.005_b0020","unstructured":"The Royal College of Pathologists of Australia, Position Statement, COVID19 IgG\/IgM Rapid POCT Tests. Available at: https:\/\/www.rcpa.edu.au\/getattachment\/bf9c7996-6467-44e6-81f2-e2e0cd71a4c7\/COVID19-IgG-IgM-RAPID-POCT-TESTS.aspx (accessed May 22, 2020)."},{"key":"10.1016\/j.cca.2020.09.005_b0025","doi-asserted-by":"crossref","unstructured":"W. Liu, L. Liu, G. Kou, et al., Evaluation of Nucleocapsid and Spike Protein-based ELISAs for 2 detecting antibodies against SARS-CoV2, J. Clin. Microbiol. (March 30, 2020). [Epub ahead of print] Doi: https:\/\/doi.org\/10.1128\/JCM.00461-20.","DOI":"10.1128\/JCM.00461-20"},{"key":"10.1016\/j.cca.2020.09.005_b0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody Responses to SARS-CoV-2 in Patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2020.09.005_b0035","unstructured":"U.S. Food and Drug Administration, Important Information on the Use of Serological (Antibody) Tests for COVID-19 - Letter to Health Care Providers. Available at: https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/important-information-use-serological-antibody-tests-covid-19-letter-health-care-providers (accessed May 22, 2020)."},{"key":"10.1016\/j.cca.2020.09.005_b0040","article-title":"Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis","volume":"370","author":"Bastos","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2020.09.005_b0045","doi-asserted-by":"crossref","unstructured":"J.J. Deeks, J. Dinnes, Y. Takwoingi, et al, Antibody tests for identification of current and past infection with SARS-CoV-2, Cochr. Database Systemat. Rev. 6 (2020) CD013652. https:\/\/doi.org\/10.1002\/14651858.CD013652.","DOI":"10.1002\/14651858.CD013652"},{"key":"10.1016\/j.cca.2020.09.005_b0050","article-title":"Covid-19: testing times","volume":"369","author":"Beeching","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2020.09.005_b0055","unstructured":"Clinical and Laboratory Standard Institute (CLSI), User Verification of Precision and Estimation of Bias; Approved Guideline-third ed., CLSI document EP15-A3, PA Wayne PA: CLSI, 2014."},{"key":"10.1016\/j.cca.2020.09.005_b0060","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention, Interim Guidelines for COVID-19 Antibody Testing. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/resources\/antibody-tests-guidelines.html (accessed June 8, 2020).","DOI":"10.46234\/ccdcw2020.085"},{"key":"10.1016\/j.cca.2020.09.005_b0065","unstructured":"US Food and Drug Administration, EUA Authorized Serology Test Performance. Available at: https:\/\/www.fda.gov\/medical-devices\/emergency-situations-medical-devices\/eua-authorized-serology-test-performance (accessed May 29, 2020)."},{"key":"10.1016\/j.cca.2020.09.005_b0070","doi-asserted-by":"crossref","unstructured":"E.S. Theel, J. Harring, H. Hilgart, D. Granger, Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2, J Clin Microbiol (June 8, 2020). [Epub ahead of print]. https:\/\/doi.org\/10.1128\/JCM.01243-20.","DOI":"10.1128\/JCM.01243-20"},{"key":"10.1016\/j.cca.2020.09.005_b0075","doi-asserted-by":"crossref","unstructured":"A. Stroemer, O. Grobe, R. Rose, H. Fickenscher, T. Lorentz, A. Krumbholz, Diagnostic accuracy of six commercial SARS-CoV-2 IgG\/total antibody assays and identification of SARS-CoV-2 neutralizing antibodies in convalescent sera, medRxiv (June 17, 2020). [Preprint] https:\/\/doi.org\/10.1101\/2020.06.15.20131672.","DOI":"10.1101\/2020.06.15.20131672"},{"key":"10.1016\/j.cca.2020.09.005_b0080","doi-asserted-by":"crossref","unstructured":"K.L. Chew, S.S. Tan, S. Saw, et al., Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection, Clin. Microbiol. Infect. (June 9, 2020). [Epub ahead of print]. https:\/\/doi.org\/10.1016\/j.cmi.2020.05.036.","DOI":"10.1016\/j.cmi.2020.05.036"},{"key":"10.1016\/j.cca.2020.09.005_b0085","unstructured":"Public Health England, Evaluation of sensitivity and specificity of four commercially available SARS-CoV-2 antibody immunoassays. Available at: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/898437\/Evaluation__of_sensitivity_and_specificity_of_4_commercially_available_SARS-CoV-2_antibody_immunoassays.pdf (accessed July 16, 2020)."},{"key":"10.1016\/j.cca.2020.09.005_b0090","doi-asserted-by":"crossref","unstructured":"M. Plebani, A. Padoan, D. Negrini, B. Carpinteri, L. Sciacovelli, Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays? Clin. Chim. Acta May 30, 2020. [Epub ahead of print] https:\/\/doi.org\/10.1016\/j.cca.2020.05.050.","DOI":"10.1101\/2020.05.22.20106328"},{"key":"10.1016\/j.cca.2020.09.005_b0095","doi-asserted-by":"crossref","unstructured":"J. Favresse, C. Eucher, M. Elsen, T.H. Marie, J.M. Dogne, J. Douxfils, Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies, Clin Chem June 2, 2020. [Epub ahead of print] https:\/\/doi.org\/10.1093\/clinchem\/hvaa131.","DOI":"10.1093\/clinchem\/hvaa131"},{"key":"10.1016\/j.cca.2020.09.005_b0100","doi-asserted-by":"crossref","unstructured":"J. Watson, P.F. Whiting, J.E. Brush, Interpreting a covid-19 test result, BMJ May 12, 2020. [Epub ahead of print] https:\/\/doi.org\/10.1136\/bmj.m1808.","DOI":"10.1136\/bmj.m1808"},{"key":"10.1016\/j.cca.2020.09.005_b0105","doi-asserted-by":"crossref","unstructured":"T. Perkmann, N. Perkmann-Nagele, M.K. Breyer, et al., Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity, Clin. Chem. 10 August, 2020. [Published online ahed of print] https:\/\/doi.org\/10.1093\/clinchem\/hvaa198.","DOI":"10.1101\/2020.06.04.20117911"},{"key":"10.1016\/j.cca.2020.09.005_b0110","doi-asserted-by":"crossref","unstructured":"K. Mizumoto, K. Kagaya, A. Zarebski, G. Chowell, Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020, Euro Surveill March 12, 2020. [Epub ahead of print]. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.10.2000180.","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000180"},{"issue":"2020","key":"10.1016\/j.cca.2020.09.005_b0115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.15585\/mmwr.mm6914e1","article-title":"Presymptomatic Transmission of SARS-CoV-2 \u2014 Singapore, January 23\u2013March 16","volume":"69","author":"Wei","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.cca.2020.09.005_b0120","unstructured":"Public Health England, Evaluation of the Abbott SARS-CoV-2 IgG for the detection of anti-SARSCoV-2 antibodies. Available at: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/887221\/PHE_Evaluation_of_Abbott_SARS_CoV_2_IgG.pdf (accessed May 26, 2020)."},{"key":"10.1016\/j.cca.2020.09.005_b0125","doi-asserted-by":"crossref","unstructured":"M.S. Tang, K.G. Hock, N.M. Logsdon, et al., Clinical Performance of Two SARS-CoV-2 Serologic Assays, Clin. Chem. May 13, 2020. [Epub ahead of print] https:\/\/doi.org\/10.1093\/clinchem\/hvaa120.","DOI":"10.1093\/clinchem\/hvaa120"},{"key":"10.1016\/j.cca.2020.09.005_b0130","doi-asserted-by":"crossref","unstructured":"A. Bryan, G. Pepper, M.H. Wener, et al., Performance Characteristics of the Abbott Architect 1 SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho, J. Clin. Microbiol. May 7, 2020. [Epub ahead of print] https:\/\/doi.org\/10.1128\/JCM.00941-20.","DOI":"10.1128\/JCM.00941-20"},{"key":"10.1016\/j.cca.2020.09.005_b0135","doi-asserted-by":"crossref","unstructured":"T. Nicol, C. Lefeuvre, O. Serri, et al., Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech), J. Clin. Virol. June 15, 2020. [Epub ahead of print] https:\/\/doi.org\/10.1016\/j.jcv.2020.104511.","DOI":"10.1016\/j.jcv.2020.104511"},{"key":"10.1016\/j.cca.2020.09.005_b0140","doi-asserted-by":"crossref","unstructured":"G. Yan, C.K. Lee, L. Lam, et al., Covert COVID-19 and false-positive dengue serology in Singapore, Lancet March 4 (2020). [Epub ahead of print] https:\/\/doi.org\/10.1016\/S1473-3099(20)30158-4.","DOI":"10.1016\/S1473-3099(20)30158-4"},{"key":"10.1016\/j.cca.2020.09.005_b0145","doi-asserted-by":"crossref","unstructured":"A.K. Nalla, A.M. Casto, M.W. Huang, et al., Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit, J. Clin. Microbiol. May 26 (2020). [Epub ahead of print] https:\/\/doi.org\/10.1128\/JCM.00557-20.","DOI":"10.1128\/JCM.00557-20"},{"key":"10.1016\/j.cca.2020.09.005_b0150","doi-asserted-by":"crossref","unstructured":"J.L. He, L. Luo, Z.D. Luo, et al., Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China, Respir Med April 21, 2020. [Published online ahead of print] https:\/\/doi.org\/10.1016\/j.rmed.2020.105980.","DOI":"10.1016\/j.rmed.2020.105980"},{"key":"10.1016\/j.cca.2020.09.005_b0155","doi-asserted-by":"crossref","unstructured":"Y. Yang, M. Yang, C. Shen, et al., Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections, medRxiv 17 February, 2020. [Preprint] https:\/\/doi.org\/10.1101\/2020.02.11.20021493.","DOI":"10.1101\/2020.02.11.20021493"},{"key":"10.1016\/j.cca.2020.09.005_b0160","doi-asserted-by":"crossref","unstructured":"J.J. Zhao, Q. Yuan, H.Y. Wang, et al., Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019, Clin. Infect Dis. 28 March (2020). [Published online ahead of print] https:\/\/doi.org\/10.1093\/cid\/ciaa344.","DOI":"10.1093\/cid\/ciaa344"},{"key":"10.1016\/j.cca.2020.09.005_b0165","doi-asserted-by":"crossref","unstructured":"I. Arevalo-Rodriguez, D. Buitrago-Garcia, D. Simancas-Racines, et al., False-negative results of initial RT-PCR assays for covid-19: a systematic review, medRxiv 13 August (2020). [Preprint] https:\/\/doi.org\/10.1101\/2020.04.16.20066787.","DOI":"10.1101\/2020.04.16.20066787"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812030437X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812030437X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:03:42Z","timestamp":1757862222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989812030437X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":33,"alternative-id":["S000989812030437X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.09.005","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of an automated chemiluminescence SARS-CoV-2 IG-G assay","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}